Ryan Martins - 03 Jan 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Reporting relationship: Chief Financial Officer
Issuer ticker: ETNB
Reported as of: 03 Jan 2023
Net transaction value: -$74,397
SEC form: 4
Accepted by SEC: 05 Jan 2023, 17:03:06 UTC
Prior SEC filing: 30 Sep 2022
Next SEC filing: 03 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Ryan A. Murr, as attorney-in-fact for Ryan Martins

Key filing fact

Ryan Martins filed Form 4 for 89bio, Inc. (ETNB) on 05 Jan 2023.

Key facts

This page summarizes Ryan Martins's Form 4 filing for 89bio, Inc. (ETNB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jan 2023, 17:03.

Change

Previous filing in this sequence was filed on 30 Sep 2022.
Current net transaction value: -$74,397.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ETNB transaction

Common Stock

Sale

Transaction value: $74,397
Shares: -5,947
Change %: -14%
Price: $12.51
Shares after: 36,368
Date: 03 Jan 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $11.94 to $12.90. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.